$91.5 Million is the total value of DAFNA Capital Management LLC's 52 reported holdings in Q3 2013. The portfolio turnover from Q2 2013 to Q3 2013 was 45.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| PCYC | PHARMACYCLICS INC | $14,120,000 | +74.0% | 102,128 | 0.0% | 15.42% | +29.9% | |
| PLX | Buy | PROTALIX BIOTHERAPEUTICS INC | $5,338,000 | +25.2% | 1,178,440 | +35.7% | 5.83% | -6.5% |
| STXS | Buy | STEREOTAXIS INC | $5,279,000 | +1439.1% | 1,585,332 | +615.7% | 5.77% | +1048.8% |
| ATRC | ATRICURE INC | $5,245,000 | +15.6% | 477,701 | 0.0% | 5.73% | -13.7% | |
| NVDQ | Sell | NOVADAQ TECHNOLOGIES INC | $4,709,000 | -24.2% | 284,041 | -38.4% | 5.14% | -43.4% |
| PODD | INSULET CORP | $4,529,000 | +15.4% | 124,981 | 0.0% | 4.95% | -13.9% | |
| INSULET CORPnote 3.750% 6/1 | $4,344,000 | +11.1% | 3,000,000 | 0.0% | 4.75% | -17.1% | ||
| DSCO | Buy | DISCOVERY LABORATORIES INC | $3,970,000 | +50.7% | 2,025,646 | +16.8% | 4.34% | +12.4% |
| NXTM | NXSTAGE MEDICAL INC | $3,312,000 | -7.8% | 251,654 | 0.0% | 3.62% | -31.2% | |
| AMPE | New | AMPIO PHARMACEUTICALS INC | $3,193,000 | – | 425,703 | +100.0% | 3.49% | – |
| BEAT | New | BIOTELEMETRY INC | $3,058,000 | – | 308,565 | +100.0% | 3.34% | – |
| GIVN | GIVEN IMAGING LTD | $3,006,000 | +37.3% | 156,320 | 0.0% | 3.28% | +2.5% | |
| ARIA | Sell | ARIAD PHARMACEUTICALS INC | $2,740,000 | -18.1% | 148,915 | -22.1% | 2.99% | -38.8% |
| CRIS | Sell | CURIS INC | $2,363,000 | +34.7% | 529,896 | -3.6% | 2.58% | +0.5% |
| NSPR | INSPIREMD INC | $1,666,000 | +5.4% | 715,200 | 0.0% | 1.82% | -21.3% | |
| CRDC | CARDICA INC | $1,383,000 | +17.2% | 1,063,469 | 0.0% | 1.51% | -12.5% | |
| New | WRIGHT MED GROUP INCnote 2.000% 8/1 | $1,229,000 | – | 1,000,000 | +100.0% | 1.34% | – | |
| CNAT | New | CONATUS PHARMACEUTICALS INC | $1,162,000 | – | 115,620 | +100.0% | 1.27% | – |
| APPY | Sell | VENAXIS INC | $1,145,000 | +37.0% | 590,000 | -15.4% | 1.25% | +2.2% |
| KBIO | Buy | KALOBIOS PHARMACEUTICALS INC | $1,130,000 | +150.0% | 250,000 | +213.1% | 1.23% | +86.4% |
| XNPT | XENOPORT INC | $1,086,000 | +14.7% | 191,262 | 0.0% | 1.19% | -14.4% | |
| BSTC | BIOSPECIFICS TECHNOLOGIES | $1,006,000 | +24.8% | 51,692 | 0.0% | 1.10% | -6.9% | |
| NUVASIVE INCnote 2.750% 7/0 | $974,000 | -1.2% | 1,000,000 | 0.0% | 1.06% | -26.3% | ||
| UPI | UROPLASTY INC | $958,000 | +59.9% | 289,332 | 0.0% | 1.05% | +19.4% | |
| SPNC | SPECTRANETICS CORP | $880,000 | -10.0% | 52,362 | 0.0% | 0.96% | -32.8% | |
| GALE | New | GALENA BIOPHARMA INC | $855,000 | – | 375,000 | +100.0% | 0.93% | – |
| CUR | New | NEURALSTEM INC | $847,000 | – | 312,500 | +100.0% | 0.92% | – |
| BOTA | New | BIOTA PHARMACEUTICALS INC | $845,000 | – | 202,157 | +100.0% | 0.92% | – |
| JNJ | JOHNSON AND JOHNSON | $815,000 | +1.0% | 9,400 | 0.0% | 0.89% | -24.6% | |
| CUTR | CUTERA INC | $789,000 | +1.0% | 88,694 | 0.0% | 0.86% | -24.6% | |
| ELOS | SYNERON MEDICAL LTD | $784,000 | -0.9% | 90,947 | 0.0% | 0.86% | -26.1% | |
| KERX | Sell | KERYX BIOPHARMACEUTICALS | $748,000 | +30.1% | 74,100 | -3.8% | 0.82% | -3.0% |
| DSCI | DERMA SCIENCES INC | $706,000 | -7.2% | 57,009 | 0.0% | 0.77% | -30.8% | |
| MACK | New | MERRIMACK PHARMACEUTICALS IN | $687,000 | – | 181,153 | +100.0% | 0.75% | – |
| EXAC | EXACTECH INC | $678,000 | +2.1% | 33,636 | 0.0% | 0.74% | -23.8% | |
| ICPT | Sell | INTERCEPT PHARMACEUTICALS IN | $663,000 | +48.0% | 9,598 | -4.0% | 0.72% | +10.4% |
| NVAX | New | NOVAVAX INC | $662,000 | – | 210,000 | +100.0% | 0.72% | – |
| RTIX | RTI SURGICAL INC | $625,000 | -0.5% | 167,058 | 0.0% | 0.68% | -25.7% | |
| DYAX | Sell | DYAX CORP | $518,000 | -74.1% | 75,500 | -86.9% | 0.57% | -80.7% |
| BAXSQ | BAXANO SURGICAL INC | $468,000 | -42.0% | 336,351 | 0.0% | 0.51% | -56.7% | |
| MASI | MASIMO CORPORATION | $466,000 | +25.6% | 17,500 | 0.0% | 0.51% | -6.3% | |
| TGTX | New | TG THERAPEUTICS INC | $378,000 | – | 75,000 | +100.0% | 0.41% | – |
| ACHN | ACHILLION PHARMACEUTICALS | $368,000 | -63.1% | 121,800 | 0.0% | 0.40% | -72.4% | |
| TGX | THERAGENICS CORP | $350,000 | +5.1% | 160,719 | 0.0% | 0.38% | -21.6% | |
| IDRA | New | IDERA PHARMACEUTICALS INC | $348,000 | – | 200,000 | +100.0% | 0.38% | – |
| GRMH | GRAYMARK HEALTHCARE INC | $284,000 | +94.5% | 693,027 | 0.0% | 0.31% | +44.9% | |
| PTN | Sell | PALATIN TECHNOLOGIES INC | $258,000 | -19.1% | 374,490 | -27.3% | 0.28% | -39.6% |
| BIOL | New | BIOLASE INC | $213,000 | – | 111,604 | +100.0% | 0.23% | – |
| TNXP | New | TONIX PHARMACEUTICALS HOLDIN | $164,000 | – | 45,000 | +100.0% | 0.18% | – |
| ADAT | AUTHENTIDATE HOLDING CORP | $126,000 | +1.6% | 142,062 | 0.0% | 0.14% | -23.8% | |
| OCRX | New | OCERA THERAPEUTICS INC | $67,000 | – | 7,894 | +100.0% | 0.07% | – |
| CBMXW | COMBIMATRIX CORP*w exp 05/01/201 | $1,000 | 0.0% | 2,325 | 0.0% | 0.00% | 0.0% | |
| DRAD | Exit | DIGIRAD CORP | $0 | – | -36,672 | -100.0% | -0.13% | – |
| CYCC | Exit | CYCLACEL PHARMACEUTICALS INC | $0 | – | -44,300 | -100.0% | -0.19% | – |
| ANAC | Exit | ANACOR PHARMACEUTICALS INC | $0 | – | -106,993 | -100.0% | -0.88% | – |
| VRTX | Exit | VERTEX PHARMACEUTICALS INC | $0 | – | -8,600 | -100.0% | -1.01% | – |
| INFU | Exit | INFUSYSTEM HOLDINGS INC | $0 | – | -474,484 | -100.0% | -1.04% | – |
| BEAT | Exit | CARDIONET INC | $0 | – | -401,788 | -100.0% | -3.47% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2013-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| STEREOTAXIS INC | 42 | Q3 2023 | 27.6% |
| ATRICURE INC | 42 | Q3 2023 | 11.4% |
| MASIMO CORPORATION | 42 | Q3 2023 | 1.8% |
| ASCENDIS PHARMA A S SPONSORED | 34 | Q3 2023 | 4.5% |
| AERIE PHARMACEUTICALS INC | 33 | Q3 2022 | 4.2% |
| GALAPAGOS NV-SPON ADR | 33 | Q3 2023 | 3.8% |
| XENON PHARMACEUTICALS INC | 33 | Q3 2023 | 3.6% |
| NEUROCRINE BIOSCIENCES INC | 32 | Q3 2023 | 2.9% |
| JOHNSON AND JOHNSON | 32 | Q1 2021 | 1.2% |
| ISHARES TR NASDQ BIOTECH | 30 | Q3 2023 | 4.0% |
View DAFNA Capital Management LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Stereotaxis, Inc. | March 08, 2018 | 13,680,554 | 23.4% |
| SUNESIS PHARMACEUTICALS INC | February 14, 2018 | 983,000 | 2.9% |
| SUNESIS PHARMACEUTICALS INC | February 14, 2017 | 1,133,583 | 5.4% |
| WINDTREE THERAPEUTICS INC /DE/ | February 14, 2017 | 208,333 | 2.4% |
| ANAVEX LIFE SCIENCES CORP.Sold out | February 16, 2016 | 0 | 0.0% |
| DISCOVERY LABORATORIES INC /DE/ | February 16, 2016 | 10,658,699 | 9.2% |
| PRECISION OPTICS CORPORATION, INC. | February 13, 2015 | 311,537 | 5.0% |
| TearLab Corp | February 14, 2013 | 939,239 | 3.2% |
| VIKING SYSTEMS INC | February 14, 2012 | 3,781,468 | 5.2% |
View DAFNA Capital Management LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G/A | 2023-02-14 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
View DAFNA Capital Management LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.